Skip to main content
logo
Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
10.25
-0.17 (-1.63%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Solid Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,099439160124105193
Market Cap Growth
145.49%174.95%29.00%17.92%-45.57%-61.33%
Enterprise Value
742225138-11-34
Last Close Price
10.255.644.006.145.3826.25

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----12.9814.17
PB Ratio
2.882.441.160.980.500.93
P/TBV Ratio
2.942.441.160.980.500.93

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.120.180.210.140.01
Net Debt / Equity Ratio
-0.96-0.93-0.91-0.77-0.87-0.99
Net Debt / EBITDA Ratio
1.700.940.980.962.012.97
Net Debt / FCF Ratio
1.901.061.241.021.832.60
Asset Turnover
----0.030.07
Quick Ratio
13.215.614.928.529.498.81
Current Ratio
13.826.145.208.949.769.43
Return on Equity (ROE)
-65.50%-109.90%-94.56%-56.79%-40.96%-42.43%
Return on Assets (ROA)
-36.38%-53.18%-45.86%-30.67%-23.95%-22.38%
Return on Capital Employed (ROCE)
-54.10%-90.00%-81.90%-69.30%-39.70%-34.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-18.84%-39.67%-78.02%-77.50%-81.84%-37.40%
FCF Yield
-17.09%-35.83%-62.99%-77.24%-96.13%-40.95%
Buyback Yield / Dilution
-80.98%-114.38%-105.27%-133.60%-19.59%-105.58%
SEC Filings: 10-K · 10-Q